SAN DIEGO, Sept. 17 /PRNewswire-FirstCall/ -- Bridgetech Holdings International, Inc. (OTC Pink Sheets: BGTH.PK), a company focused on maximizing the potential of emerging healthcare products and services in China and the U.S., today announced the highly anticipated launch of http://www.jk1.cn/ -- the first non-profit international healthcare web portal developed in collaboration with leading healthcare institutions and organizations in China and the US. The portal was launched successfully with sourced content in both English and Chinese today in Beijing, China.

JK1 provides the Chinese readers with accurate healthcare and medical information spanning a wide range of subjects including information on the treatment, screening and prevention of life-threatening diseases such as cancer as well as hundreds of other common healthcare conditions in China. JK1 has two sections -- the public and the professional sections. While the former was successfully launched today, the latter will open at a later stage.

JK1 is the first healthcare web portal in China to source contents from world renowned institutions such as the U.S. Government's National Cancer Institute (NCI) and the Agency for Healthcare Research and Quality (AHRQ), as well as leading academic institutions including Harvard University, Stanford University, University of Vanderbilt and other well known institutions in the U.S. In addition, under a strategic alliance agreement N.C.N. Limited, a wholly-owned subsidiary of Xinhua News Agency, will supply JK1 with Chinese news articles relating to medical and healthcare topics.

"This is an important day for China. The launching of the public section of JK1 provides the Chinese public with a much-needed resource on common diseases, as well as the most prevalent types of severe ailments such as cancer and their treatment options. JK1 will contribute towards cultivating a better informed public in China to care for themselves and to be more healthy When the professional section opens, the Chinese medical professionals will be equipped with a powerful tool to enhance their clinical and medical research," said Michael Chermak, Chairman and CEO of Bridgetech. "JK1 is a one-stop portal at a mouse click away, serving China 24 hours a day free of charge,"

The launch of the JK1 healthcare portal is a milestone achievement of the Sino-US Medical Exchange Foundation ("Sino-US Foundation") and Guangzhou Bridgetech Medical Technologies Development Co., Ltd. ("GBMT"), a wholly owned subsidiary of BTHI with a mission to provide access by the Chinese community to the world's most advanced sciences. Both the Sino-US Foundation and the JK1 healthcare portal are funded by Bridgetech,

"At Bridgetech, our motto is 'Doing Well by Doing Good'. The inspiration behind JK1 was our founding Chairman, Hong Kong-born Chinese Dr. Herbert Wong Yao Sing. Dr. Wong passed away in June 2006 at the prime age of 53, after battling lung cancer. He was dedicated to facilitating dialogue and exchanges between the medical professionals in China and the U.S. Bridgetech was Herbert's idea to create a company that could offer shareholders a significant opportunity while advancing the fight against cancer -- a win-win by doing well financially for shareholders as we do good for society. China was Herbert's home and he wanted to make a difference. China was his passion," added Mr. Chermak.

Carrie Yuen, Bridgetech' President in Asia, showcased live how to access JK1 for information on two of the most common diseases in China -- osteoporosis and breast cancer -- in front of an audience comprising government officials from China and Hong Kong, overseas and local guests and local and international reporters.

Witnessing the launch today also were representatives from the Wu Jieping Medical Foundation, China Anti-Cancer Association, 301 Hospital, People's Hospital and Xinhua News Agency.

About JK1.CN

The JK1 healthcare web portal is an international, non-profit collaboration sponsored, created and managed by Bridgetech Holdings International, Inc between leading healthcare institutions and organizations in China and the United States (NCI AHRQ, Stanford University, Harvard Public Health, and Xinhua News Agency). The portal will provide China's consumers with responsible and accurate general healthcare and oncology information. It will afford professionals opportunities to collaborate with their colleagues domestically and overseas and it will keep consumers and professionals advised of the latest medical advances, especially in the critical area of oncology. For additional information, please visit JK1 at http://www.jk1.cn/.

About Bridgetech Holdings International, Inc.

Bridgetech is leveraging its extensive network of relationships in China and the U.S. to capitalize on the demand for Western healthcare in Greater China. The company is bringing emerging drugs, devices and diagnostics to Greater China, with an initial focus on oncology. For additional information, please visit Bridgetech at http://www.bthi.com/.

Forward-Looking Statements

Statements contained in this press release that are not statements of historical fact are "forward-looking statements" as that term is defined under federal securities laws, including, without limitation, all statements concerning expectations, beliefs, goals, intention or strategies for the future of Bridgetech. Forward-looking statements may be identified by words such as "goals," "plans," "believes," "will," "expects" and other words of similar meaning used in conjunction with, among other things, discussions of future operations, financial performance, product development and new ventures. Many factors could cause actual events or results to differ materially from those expressed in any forward-looking statement. Investors are cautioned not to place any undue reliance on any forward-looking statements.

Contacts: Media Relations US: Vince Heald, Beck Ellman Heald -- (858) 453-9600 vheald@behmedia.com Media Relations Hong Kong: Andrew Cheung, A-World Consulting -- (852) 2114 4976 / 9205 2610 andrew.cheung@a-world.com.hk Investor Relations: Redwood Consultants, LLC -- 415-884-0348

CONTACT: US, Vince Heald of Beck Ellman Heald, +1-858-453-9600,
vheald@behmedia.com; Hong Kong, Andrew Cheung of A-World Consulting,
(852) 2114 4976 or 9205 2610, andrew.cheung@a-world.com.hk; or Investor
Relations, Redwood Consultants, LLC, +1-415-884-0348, all for Bridgetech
Holdings International, Inc.

Web site: http://www.bthi.com/
http://www.jk1.cn/